Masala A, Delitala G, Alagna S, Devilla L
Clin Endocrinol (Oxf). 1977 Sep;7(3):253-6. doi: 10.1111/j.1365-2265.1977.tb01321.x.
Serum growth hormone (GH) behaviour after levodopa administration was measured in twelve healthy subjects both in basal conditions and after a 4 day course of pimozide (4 mg daily), a specific blocker of dopamine (DA) receptors. In addition, fasting plasma GH was measured on the first, second and third day of treatment. No significant difference was found between GH response to levodopa in basal conditions and after pimozide; moreover, fasting GH was uninfluenced by pimozide.
在12名健康受试者中，测量了他们在基础状态下以及服用4天匹莫齐特（每日4毫克，一种多巴胺（DA）受体特异性阻滞剂）后的左旋多巴给药后血清生长激素（GH）的变化情况。此外，在治疗的第一天、第二天和第三天测量空腹血浆GH。基础状态下和服用匹莫齐特后，GH对左旋多巴的反应未发现显著差异；此外，空腹GH不受匹莫齐特影响。
